SA SurveyAnchor

Past Winning Plans

Real state-approved Plans of Correction and their spot-check schedules.

Browse State Guides →
Clear
F0756 · Bethlehem South Skilled Nursing and Rehabilitation Center (PA)
Surveyed 06/30/2026 · Spot-checks: weekly for 4 weeks
✓ Passed Re-Inspection Use F0756 →

1. Corrective Action for the Resident(s) Found to be Affected: Resident #1 identified during the survey will have an interdisciplinary review completed, to determine the continued clinical…

View Full Plan Text
F0756 Correction Date: 07/13/2026 1. Corrective Action for the Resident(s) Found to be Affected: Resident #1 identified during the survey will have an interdisciplinary review completed, to determine the continued clinical indication for the medication(s) cited. The medication in question has been removed for now, until further evaluation. Non pharmacological interventions updated in care plan. 2. Identification of Other Residents Who May Be Affected: All residents with an anti anxiety medication order have the potential to be affected by the alleged deficient practice. All anti anxiety medications orders reviewed and care plans updated with non-pharm interventions as indicated. 3. Systemic Changes to Prevent Recurrence: Staff members will receive education regarding: Use of non-pharmacological interventions prior to administering antianxiety medications. The interdisciplinary team will review all new orders for antianxiety medications in the morning clinical meeting. 4. Monitoring to Ensure Continued Compliance: The Director of Nursing or designee will review all new anti-anxiety medication orders weekly until substantial compliance is met. Quality Assurance: Findings will be presented to the Quality Assurance and Performance Improvement (QAPI) Committee monthly to ensure the process remains effective.
F0756 · Lebanon Skilled Nursing and Rehabilitation Center (PA)
Surveyed 04/17/2026 · Spot-checks: monthly for 4 weeks
✓ Passed Re-Inspection Use F0756 →

The statements made on this plan of correction are not an admission to and do not constitute an agreement with the alleged deficiencies. To remain in compliance with all federal and state…

View Full Plan Text
F0756 Correction Date: 05/26/2026 The statements made on this plan of correction are not an admission to and do not constitute an agreement with the alleged deficiencies. To remain in compliance with all federal and state regulations, the facility has taken or will take actions set forth in the following plan of correction. Residents #6 and #12 providers have been provided with the identified Pharmacy recommendations for acknowledgment or action. A facility wide initial audit of facility residents' March and April Pharmacy Recommendations will be completed by the Director of Nursing or designee to ensure his\her provider has acknowledged or acted upon the recommendations. Corrections will be made as necessary. Education will be provided to the Director of Nursing and Unit Managers on the policy Medication Regimen Review and Reporting. A monthly audit will be conducted by the Director of Nursing or designee x three months to ensure pharmacy recommendations have been acknowledged or acted upon. Results will be corrected as necessary and audit results will be reported at the Quality Assurance Performance Improvement Meeting.
F0756 · Chambers Pointe Health Care Center (PA)
Surveyed 03/25/2026 · Spot-checks: weekly for 4 weeks
✓ Passed Re-Inspection Use F0756 →

1. Resident 42 medical administration records and care plan were reviewed and updated with non-pharmacological interventions to offer prior to administration of as needed (PRN) psychotropic…

View Full Plan Text
F0756 Correction Date: 05/01/2026 1. Resident 42 medical administration records and care plan were reviewed and updated with non-pharmacological interventions to offer prior to administration of as needed (PRN) psychotropic medication. 2. Physician orders and care plans for residents with PRN psychotropic orders were reviewed and updated with non-pharmacological interventions to offer prior to administration of PRN psychotropic medication. 3. Policy for Nonpharmacological Interventions Prior to PRN Psychotropic Medications was reviewed and updated. Nursing staff were re-educated to policy and procedure changes regarding use of non-pharmacological interventions. 4. Weekly audits by Director of Nursing or designee of 5 (10%) of residents' medication administration and health records will be reviewed weekly times 5 weeks for compliance of non-pharmacological intervention use prior to giving psychotropic medication. Any noted non-compliance will receive immediate additional re-education. Copies of all audits will be given to the Nursing Home Administrator. Results of the audits will be presented during the monthly Quality Assurance Performance Improvement meeting.
F0756 · Carnegie Park Post Acute (PA)
Surveyed 03/13/2026 · Spot-checks: monthly for 4 weeks
✓ Passed Re-Inspection Use F0756 →

A review of the medical record for residents R2 and R22 will be conducted. The review will be completed by the director of nursing in collaboration with the attending physician. The results of…

View Full Plan Text
F0756 Correction Date: 04/27/2026 A review of the medical record for residents R2 and R22 will be conducted. The review will be completed by the director of nursing in collaboration with the attending physician. The results of this review will be documented on the pharmacy consultation form, either accepting the recommendation (and changing the order) or providing a clinical rationale for declining it. The clinical team will audit the medical records to ensure that any previous pharmacy recommendations from the last 30 days have been reviewed and properly documented on the pharmacy consultation form, either accepting the recommendation (and changing the order) or providing a clinical rationale for declining it. The regional director of clinical services will educate the director of nursing and assistant director of nursing on the importance of following up on pharmacy recommendations timely and appropriately. A continuing audit will be conducted on monthly pharmacy recommendations/reviews to ensure compliance with timely and appropriate follow up x 3 months. The results of these audits will be presented by the DON to the Quality Assurance and Performance Improvement (QAPI) committee during monthly meetings. The QAPI committee will review the data to ensure sustained compliance and determine if further action or adjustments to the auditing schedule are necessary. The facility will be in compliance with F0756 by April 27th, 2026.
F0756 · Pine Run Health Center (PA)
Surveyed 03/12/2026 · Spot-checks: monthly for 3 months
✓ Passed Re-Inspection Use F0756 →

Plan of Correction Pharmacy Recommendations (F-0756) 1) Residents 9 and 37 pharmacist recommendations were not addressed by the physician. Physician was notified. 2) DON or designee will…

View Full Plan Text
F0756 Correction Date: 04/10/2026 Plan of Correction Pharmacy Recommendations (F-0756) 1) Residents 9 and 37 pharmacist recommendations were not addressed by the physician. Physician was notified. 2) DON or designee will conduct an audit of pharmacy recommendations for the month of February to ensure pharmacy recommendations were acknowledged by the physician and addressed as appropriate. Variances will be addressed 3) DON re-educated on the Consultant Pharmacist Report Documentation and communication of consultant pharmacist recommendation policy. 4) DON or designee will audit 5 random residents monthly for 3 months to verify that the that the physician acknowledged residents' pharmacy recommendations and addressed as appropriate and per policy. Audits will be brought to the Quality Assurance meeting with reviews and recommendations as needed. 5) Date of compliance is scheduled for. 4/10/2026
F0756 · Concordia at Spiritrust Sprenkle Drive (PA)
Surveyed 11/18/2025 · Spot-checks: monthly for 4 weeks
✓ Passed Re-Inspection Use F0756 →

The facility failed to ensure that residents who use psychotropic drugs receive gradual dose reductions and behavioral interventions, unless clinically contraindicated, in an effort to…

View Full Plan Text
F0756 Correction Date: 12/12/2025 The facility failed to ensure that residents who use psychotropic drugs receive gradual dose reductions and behavioral interventions, unless clinically contraindicated, in an effort to discontinue these drugs. The facility is unable to correct the deficiency as is related to Resident 8's July pharmacy recommendation. The facility will complete a whole house audit of psychotropic medication pharmacy recommendations for the previous 60 days. Any missed recommendations identified in the audit will be noted and addressed with MD to reflect the accurate recommend dose and frequency of medication DON will re-educate the licensed nursing staff on the process of reviewing, transcribing, and implementing pharmacy recommendations. DON/designee will complete a monthly audit of pharmacy recommendations related to antipsychotic medications for a period of 3 months. Findings will be reported in QAPI. Continued need for audits will be determined by the QAPI Committee. December 12, 2025
F0756 · Providence Point Healthcare Residence (PA)
Surveyed 06/18/2025 · Spot-checks: daily for 4 weeks
✓ Passed Re-Inspection Use F0756 →

R10 medical record reviewed. R10's MD was contacted to review medications and dx. RNAC educated the nursing staff on the acceptable dx for such medications. Anti-psychotropic meeting is held…

View Full Plan Text
F0756 Correction Date: 08/04/2025 R10 medical record reviewed. R10's MD was contacted to review medications and dx. RNAC educated the nursing staff on the acceptable dx for such medications. Anti-psychotropic meeting is held monthly with the IDT to review residents/medications/dx. Pharmacy consultant also reviews existing and new admission. Any resident who is on psychotic medications are checked for correct dx, and behavior charting. Audits will be conducted on residents that are currently on psychotropic medications to make sure that all have appropriate dx and behavior charting by the RN supervisor/DON/SS daily x2 weeks, weekly x4 weeks and monthly x2. Audits will be reviewed at the quarterly QA committee.
F0756 · Kadima Rehabilitation & Nursing at Pottstown (PA)
Surveyed 10/09/2026 · Spot-checks: monthly for 3 months
Approved Filing Use F0756 →

1.) Resident 22 medication regimen will be reviewed an addressed by the attending physician. 2.) The facility will complete a 30-day look back of the pharmacists' recommendations/ medication…

View Full Plan Text
F0756 Correction Date: 11/11/2026 1.) Resident 22 medication regimen will be reviewed an addressed by the attending physician. 2.) The facility will complete a 30-day look back of the pharmacists' recommendations/ medication regimens to validate that they have been reviewed and addressed by the physician. 3.) The Regional Clinical Consultant or designee will re-educate the Director of Nursing on federal regulation 0756, detailing ensuring pharmacist recommendations/medication regimens are reviewed and addressed by the physician. 4.) The Director of Nursing or designee will complete an audit monthly for 3 months to ensure medication regimen reviews from the consulting pharmacist are reviewed and addressed by the physician. The results will be submitted to the QAPI Committee for review and analysis for ongoing monitoring
F0756 · Cedar Crest Post Acute (PA)
Surveyed 10/07/2026 · Spot-checks: weekly for 4 weeks
Approved Filing Use F0756 →

The statements made on this plan of correction are not an admission to and do not constitute an agreement with the alleged deficiencies herein. To remain in compliance with all federal and…

View Full Plan Text
F0756 Correction Date: 11/18/2026 The statements made on this plan of correction are not an admission to and do not constitute an agreement with the alleged deficiencies herein. To remain in compliance with all federal and state regulations the center has taken or will take the actions set forth in the following plan of correction. 1.Resident 9's physician order for PRN lorazepam was updated to include a 14 day end date. 2.The DON or designee will conduct a review of residents receiving PRN psychotropic medications to identify current orders that lack a specified duration or stop date, or that continue beyond 14 days without documented prescriber evaluation and rationale. Any identified discrepancies will be referred to the attending physician for review and clarification. 3.The DON or designee will educate licensed nursing staff on ensuring all PRN psychoactive medications have a specific duration, stop date and any medication that continues beyond 14 days needs documented prescriber evaluation and rationale. 4.The DON or designee will audit PRN psychotropic medication orders weekly for the first four weeks then monthly x 2 to verify that orders contain the required duration and or stop date, and that continued use beyond 14 days is supported by the required prescriber evaluation and documentation. Identified deficiencies will be corrected promptly. Audit findings will be reviewed at Quality Assurance and Performance Improvement (QAPI) meeting monthly with additional interventions implemented as needed.
F0756 · Little Sisters of the Poor (PA)
Surveyed 10/01/2026 · Spot-checks: weekly for 4 weeks
Approved Filing Use F0756 →

The medication regimens for Residents R1 and R38 were reviewed. Medication side-effect and behavior monitoring were activated in the electronic medical records for both residents.…

View Full Plan Text
F0756 Correction Date: 11/12/2026 - The medication regimens for Residents R1 and R38 were reviewed. Medication side-effect and behavior monitoring were activated in the electronic medical records for both residents. Individualized nonpharmacological interventions were implemented and documented for Resident R1 and R38, and the effectiveness of prescribed pharmacological interventions was evaluated. - The Director of Nursing or designee will conduct a facility-wide audit of residents receiving psychotropic medications to ensure individualized behavior monitoring, medication side-effect monitoring, nonpharmacological interventions, and evaluation of medication effectiveness are implemented and documented. Identified deficiencies will be corrected, and care plans will be updated as indicated. - Licensed nursing professionals will be re-educated on applicable regulatory requirements and facility policies regarding psychotropic medication management, including behavior and medication side-effect monitoring, individualized nonpharmacological interventions, evaluation of pharmacological effectiveness, and required clinical documentation. - The Social Services Department, in collaboration with the Director of Nursing or designee, will audit residents receiving psychotropic medications to verify appropriate behavior and side-effect monitoring, documentation of nonpharmacological interventions, and evaluation of medication effectiveness. Audits will be conducted weekly for four weeks, monthly for one month, and quarterly for one quarter. Findings will be reported to the Quality Assurance and Performance Improvement (QAPI) Committee for review and corrective action as indicated. - Date of Compliance: November 12, 2026.
F0756 · Embassy of Scranton (PA)
Surveyed 09/30/2026 · Spot-checks: weekly for 4 weeks
Approved Filing Use F0756 →

1. Resident 2 was reviewed by our psych services provider to ensure proper management of psychotropic medication and recommendation for a gradual dose reduction. Resident #2 has discharged to…

View Full Plan Text
F0756 Correction Date: 11/11/2026 1. Resident 2 was reviewed by our psych services provider to ensure proper management of psychotropic medication and recommendation for a gradual dose reduction. Resident #2 has discharged to an inpatient hospice unit. 2. Current residents who are receiving psychotropic medications were reviewed to ensure residents have been evaluated and have written justification by the physician for the prescribed psychoactive medication and dosage. 3. Licensed nurses were educated on to ensure to administer psychoactive medication according to current orders checked for accuracy, education will be provided to ensure evaluation of need for prescribed psychoactive medication side and written justification for use and dosage of prescribed psychoactive medication. 4. Administrator/DON/designee will audit random residents receiving antipsychotic medications to ensure correct psychoactive medication and written evaluation and justification by physician for prescribed psychoactive medications. Weekly x4 then monthly x2 and report findings to QAPI committee.
F0756 · Harborview Rehabilitation and Care Center at Doylestown (PA)
Surveyed 09/18/2026 · Spot-checks: weekly for 4 weeks
Approved Filing Use F0756 →

PRN Psychiatric Medication 1. The physician was contacted to review the continued use and rationale for the cited PRN psychiatric medications. Non-pharmacological interventions were…

View Full Plan Text
F0756 Correction Date: 10/06/2026 F0605 PRN Psychiatric Medication 1. The physician was contacted to review the continued use and rationale for the cited PRN psychiatric medications. Non-pharmacological interventions were reinforced. 2. Reeducation was provided to licensed nursing staff regarding PRN psychiatric medications and attempting/documenting non-pharmacological interventions prior to administration when appropriate. 3. A facility-wide audit was conducted to determine if all PRN psychiatric medications had a rationale for their continued use and to determine if the nurse administering the medication had offered non-pharmacological interventions prior to administration for the last 30 days. 4. DON/designee will conduct weekly audits X4, then monthly audits X3. Results of the audits will be presented to the Quality Assurance Committee for review.
F0756 · Independence Rehab and Nursing (PA)
Surveyed 09/08/2026 · Spot-checks: weekly for 4 weeks
Approved Filing Use F0756 →

1. Resident 11 will be reviewed by MD to ensure recommendations are addressed. 2. Facility will review pharmacy recommendations for the last 30 days to ensure recommendations are complete. 3.…

View Full Plan Text
F0756 Correction Date: 10/09/2026 1. Resident 11 will be reviewed by MD to ensure recommendations are addressed. 2. Facility will review pharmacy recommendations for the last 30 days to ensure recommendations are complete. 3. Unit manager will be in serviced on pharmacy recommendation policy. 4. Pharmacy reccomendations will be audited by DON or designee as reports become available over course of x4 weeks followed by monthgly x2 months Results reported to QAPI
F0756 · Riverstreet Manor (PA)
Surveyed 09/02/2026 · Spot-checks: daily for 4 weeks
Approved Filing Use F0756 →

1. Resident #1 as needed Ativan order was reviewed with medical provider and behavioral health group and ordered was discontinued. 2. An audit will be completed on all residents with orders…

View Full Plan Text
F0756 Correction Date: 10/02/2026 1. Resident #1 as needed Ativan order was reviewed with medical provider and behavioral health group and ordered was discontinued. 2. An audit will be completed on all residents with orders for as needed medications to ensure appropriate documentation of behaviors and non-pharmacological interventions prior to administration of as needed psychotropic medications. 3. Professional staff will be re-educated on Psychotropic Medication Use policy. Daily audits will be completed by ADON/designee for 4 weeks and monthly for 2 months to ensure appropriate documentation of behaviors and non-pharmacological interventions prior to administration of as needed psychotropic medications. 4. Results of these daily audits will be reviewed in monthly QAPI meeting until substantial compliance is achieved. 5. Facility compliance date will be October 2, 2026.
F0756 · King of Prussia Skilled Nursing and Rehabilitation Center (PA)
Surveyed 08/14/2026 · Spot-checks: weekly for 4 weeks
Approved Filing Use F0756 →

Step 1: The pharmacy recommendations for residents 53 and 108. Physician responses could not be retroactively corrected. Step 2: DON/Designee will complete an audit of current pharmacy…

View Full Plan Text
F0756 Correction Date: 09/30/2026 Step 1: The pharmacy recommendations for residents 53 and 108. Physician responses could not be retroactively corrected. Step 2: DON/Designee will complete an audit of current pharmacy medication regimen review recommendations of the preceding month to ensure each recommendation had been reviewed and acted upon by the physician, including appropriate signature/date, implementation of accepted recommendations, or documented clinical rationale when a recommendation was declined. Any identified refusal to recommendation has a reason. Step 3: DON/NPE/Designee re-educated licensed nursing staff and applicable providers regarding the pharmacy medication regimen review process. Education included ensuring pharmacy recommendations are promptly forwarded to the physician, physician responses are dated and documented, accepted recommendations are implemented, and a clinical rationale is documented when the physician declines a pharmacist recommendation when required. Step 4: DON/Designee will audit pharmacy recommendations weekly X 4 weeks, then monthly X 2 months to ensure recommendations are reviewed, appropriately acted upon, physician responses/rationales are documented, and resulting orders are implemented. DON/Designee will report audit findings to the QAPI Committee X 3 months for review and additional recommendations as indicated.
F0756 · The Gardens at Camp Hill (PA)
Surveyed 08/13/2026 · Spot-checks: monthly for 4 weeks
Approved Filing Use F0756 →

1. Resident 1 orders for questran were updated with appropriate time frames. No ill effects noted to resident. 2. July/August pharmacy regimen reviews to be reviewed for completion to ensure…

View Full Plan Text
F0756 Correction Date: 09/15/2026 1. Resident 1 orders for questran were updated with appropriate time frames. No ill effects noted to resident. 2. July/August pharmacy regimen reviews to be reviewed for completion to ensure no residents were affected by this alleged deficient practice, and reissued to physician as appropriate. 3. Education was provided to RN supervisors on pharmacy recommendations not responded to within 14 days, will be reissued to physician for completion before next review; and if accepted the recommendation needs to be fully implemented in the orders including any special dosing instructions. 4. The Director of Nursing or assigned designee will conduct audits bimonthly x 4 weeks, then monthly x 2 months. The results of these audits will be presented to the QAPI committee for review.
F0756 · Aventura at Pembrooke (PA)
Surveyed 07/29/2026 · Spot-checks: monthly for 4 weeks
Approved Filing Use F0756 →

Based upon clinical record review and interviews, it was determined that the facility failed to ensure that medication irregularities were appropriately acted upon by a physician for one of…

View Full Plan Text
F0756 Correction Date: 09/11/2026 Based upon clinical record review and interviews, it was determined that the facility failed to ensure that medication irregularities were appropriately acted upon by a physician for one of five residents reviewed (Resident 3). Assessment for resident 3 was completed. No irregularities were identified. Director Of Nursing/designee completed a 30-day House wide audit. No irregularities identified. ADMINISTRATOR/designee to educate Physician by 11SEP2026 to review pharmacy orders and address irregularities as identified. Director Of Nursing/Designee to audit monthly x3 months. Results will be submitted quarterly to the Quality Assurance Performance Improvement Committee for review and recommendations.
F0756 · Midtown Oaks Health & Rehab Center (PA)
Surveyed 07/15/2026 · Spot-checks: weekly for 4 weeks
Approved Filing Use F0756 →

Step 1: Resident #7, and Resident# 78 pharmacy recommendations were reviewed and completed by Medical Director, and the medical record was updated to reflect the physician's response. Step2:…

View Full Plan Text
F0756 Correction Date: 08/18/2026 Step 1: Resident #7, and Resident# 78 pharmacy recommendations were reviewed and completed by Medical Director, and the medical record was updated to reflect the physician's response. Step2: To identify other residents that have the potential to be affected, the Director of Nursing/Designee completed an audit of pharmacy recommendations issued within the previous 30 days to ensure completion. Step 3: To prevent reoccurrence, the Director of Nursing/Designee will re-educate licensed staff on the Medication Regimen Review policy. Step4: To monitor and maintain ongoing compliance, the Director of Nursing/designee will review consultant pharmacist recommendations weekly for four weeks, then monthly for two months to ensure timely physician response and appropriate documentation. The results of the audits will be forwarded to the facility's Quality Assurance Performance Improvement (QAPI) committee for further review and recommendations
F0756 · Concordia at Spiritrust Luther Ridge (PA)
Surveyed 06/11/2026 · Spot-checks: weekly for 4 weeks
Approved Filing Use F0756 →

Correction does not constitute an admission of or an agreement with the facts and conclusions set forth on the survey report. Our plan of correction is prepared and executed as a means to…

View Full Plan Text
F0756 Correction Date: 08/10/2026 Correction does not constitute an admission of or an agreement with the facts and conclusions set forth on the survey report. Our plan of correction is prepared and executed as a means to continually improve the quality of care and to comply with all applicable state and federal regulatory requirements. The facility is currently having the pharmacy consultant complete monthly medication reviews. The facility is currently having the physicians respond to the monthly consultant pharmacy reviews. Current patients have the potential to be affected. The facility will complete an audit on the consultant pharmacy medication reviews for the month of June to validate each current patient had a pharmacy consultant review and the attending physician addressed the recommendations made by the consultant pharmacist. DON/Designee will educate the physicians the facility's policy Drug Regime Review. The DON and/or designee will complete a weekly audit x 4 weeks and randomly x 2 months to validate monthly consultant pharmacist reviews are being addressed by the attending physicians. Findings will be reported to Quality Assurance for review and recommendations.
F0756 · Redstone Highlands Health Care Ctr (PA)
Surveyed 04/16/2026 · Spot-checks: weekly for 4 weeks
Approved Filing Use F0756 →

The psychotropic consent for Resident 2 for Aripiprazole was immediately obtained. Resident 2 had no adverse effects from receiving the medication as ordered without having a psychotropic…

View Full Plan Text
F0756 Correction Date: 05/19/2026 The psychotropic consent for Resident 2 for Aripiprazole was immediately obtained. Resident 2 had no adverse effects from receiving the medication as ordered without having a psychotropic consent on file. A facility-wide sweep for all psychotropic consents was completed. Any issues identified were corrected at the time of discovery. All nursing staff were re-educated on F605 and the psychotropic medication policy. Director of Nursing or designee will conduct audits to ensure that psychotropic medication consents are documented 3x per week x 4 weeks then weekly x 2 months. Identified issues will be addressed at the time of discovery. Audit results will be reported to the Quality Assurance Performance Improvement committee to identify trends and further opportunities for improvement and needs for additional staff training and education.
F0756 · Marywood Heights (PA)
Surveyed 03/26/2026 · Spot-checks: weekly for 4 weeks
Approved Filing Use F0756 →

1. Resident 36 had antipsychotic medication and diagnosis reviewed by physician. 2. Director of Nursing or designee will complete an audit of current residents on antipsychotic medications to…

View Full Plan Text
F0756 Correction Date: 04/29/2026 1. Resident 36 had antipsychotic medication and diagnosis reviewed by physician. 2. Director of Nursing or designee will complete an audit of current residents on antipsychotic medications to ensure that the clinical record contains justification of medication, non pharmacological interventions attempted, resident behaviors assessed by facility were addressed, and documentation of symptoms. 3. Physicians, Interdisciplinary team, and licensed nursing staff will be educated on the Psychotropic Drug Use policy and regulation, in addition to the review of resident's documentation to ensure appropriate justification of medication. Licensed nurses and IDT team will be educated on documentation in the clinical record regarding medical symptoms, resident behaviors/behavioral monitoring, and interventions. 4. Director of Nursing or designee will complete weekly audits times 4 weeks of new residents or current residents with new orders for antipsychotic medications to ensure that the clinical record contains justification of medication, non pharmacological interventions attempted, resident behaviors assessed by facility, and documentation of symptoms prior to MD order of antipsychotic medication. 5. Facility will be in compliance on 4/29/26.
F0756 · Rest Haven-York (PA)
Surveyed 02/05/2026 · Spot-checks: weekly for 4 weeks
Approved Filing Use F0756 →

Received consent for resident R15and R45 to receive antipsychotic and antidepressant medications as ordered by physician/CRNP. All residents on antipsychotic and antidepressant medications…

View Full Plan Text
F0756 Correction Date: 04/06/2026 Received consent for resident R15and R45 to receive antipsychotic and antidepressant medications as ordered by physician/CRNP. All residents on antipsychotic and antidepressant medications were evaluated for consent to receive medication by the resident or resident representative. Antipsychotic/Antidepressant medication policy updated to include that consent will be received from resident or resident representative before administering medications. Licensed staff will be educated on policy revision. A QA tool has been developed to review 10% of residents taking antipsychotic and antidepressant medications weekly to ensure that consent was received from resident or resident representative before administration of antipsychotic medications. The Quality Assurance (QA) Coordinator or designee will complete the QA review on a weekly basis and re-educate staff not following policy and procedure. The QA Coordinator will review the completed QA tool monthly and will report any trends or patterns at the quarterly Interdisciplinary Quality Assurance and Quality Performance (QAPI) meeting. The QAPI Committee will review the reports at their quarterly meeting and make recommendations for any deficient patterns identified. They will continue to monitor quarterly until the solutions are sustained for a period of two quarters. Decreasing or elimination of this tool will occur only upon recommendation of the Interdisciplinary QAPI Committee at their quarterly meeting.
F0756 · Allied Services Meade Street Skilled Nursing (PA)
Surveyed 01/16/2026 · Spot-checks: weekly for 4 weeks
Approved Filing Use F0756 →

Resident #81 will have the pharmacy recommendations related to 2 antidepressants reviewed by MD and documented risk-versus-benefit analysis to support continued use of both medications or a…

View Full Plan Text
F0756 Correction Date: 02/17/2026 Resident #81 will have the pharmacy recommendations related to 2 antidepressants reviewed by MD and documented risk-versus-benefit analysis to support continued use of both medications or a GDR will be completed. Current residents receiving 2 antidepressants will be reviewed by MD and documented risk-versus-benefit analysis to support continued use of both medications or a GDR will be completed. Staff Development/Designee will re-inservice MD's, Physician Extenders, and Professional Nursing Staff on the Consultant Pharmacy Review Policy. DON/Designee will complete a weekly audit on random residents ordered 2 antidepressants to ensure appropriate documentation is present. Results of audits will be presented at the monthly Quality Assurance Performance Improvement Meeting for review and/or recommendations.